Health
Healthcare
2014 IPO

Diplomat Pharmacy

$5.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.20 (3.50%) Today
+$0.20 (3.50%) Today

Why Robinhood?

You can buy or sell DPLO and other stocks, options, ETFs, and crypto commission-free!

About

Diplomat Pharmacy, Inc. engages in the provision of pharmacy services. It focuses on improving the lives of patients with complex chronic diseases while delivering solutions for manufacturers, hospitals, payers, and providers.The company was founded by Dale Hagerman and Philip Hagerman in 1975 and is headquartered in Flint, MI.

Employees
2,335
Headquarters
Flint, Michigan
Founded
1975
Market Cap
426.00M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.07M
High Today
$5.99
Low Today
$5.61
Open Price
$5.65
Volume
250.31K
52 Week High
$28.74
52 Week Low
$5.16

Collections

Health
Healthcare
2014 IPO
US
North America

News

Guru FocusMar 17

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DPLO, SYNH, BPI and CNDT

NEW YORK, March 17, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies.

158
The Motley FoolMar 16

Diplomat Pharmacy Inc (DPLO) Q4 2018 Earnings Conference Call Transcript

Diplomat Pharmacy Inc (NYSE:DPLO) Q4 2018 Earnings Conference Call March 15, 2019, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Hello and welcome to Diplomat's fourth quarter 2018 and full-year 2018 earnings conference call. At this time, I would like to inform all participants that their lines will be in a listen-only mode. After the speakers' remarks, there will be a question and answer period. I'd like to turn the call over to Terri A...

196
Markets InsiderMar 15

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Diplomat Pharmacy, Inc. To Contact The Firm

NEW YORK, March 15, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Diplomat Pharmacy, Inc.

102

Earnings

$0.00
$0.08
$0.17
$0.25
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
$0.23 per share
Actual
$0.13 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.